zur Navigation zum Inhalt
 
Onkologie 7. August 2014

Follow-up in aggressive lymphomas

A number of important contributions to the clinical knowledge of aggressive B-cell lymphoma were published over the past year. Among potential practice-changing studies—or those preventing unjustified change, were studies on improved risk classification, dose-dense immunochemotherapy, early autologous stem-cell transplantation, and the first clinical report on the use of immune checkpoint blockade to improve outcome of high-dose therapy.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben